These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 3163134)

  • 1. Evaluation of serum fucose level in patients with oral cancer.
    Ghosh M; Raghavan MR; Nayak BR; Bailoor DN
    Oral Surg Oral Med Oral Pathol; 1988 Apr; 65(4):418-20. PubMed ID: 3163134
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Study of serum fucose and serum sialic acid levels in oral squamous cell carcinomia.
    Shashikanth MC; Rao BB
    Indian J Dent Res; 1994; 5(4):119-24. PubMed ID: 9495093
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum sialic acid, fucose, sialic acid/fucose ratio as tumor markers in oral cancer.
    Ghosh M; Nayak BR
    Ann Dent; 1991; 50(2):33-5, 48. PubMed ID: 1785913
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circulating levels in serum of total sialic acid, lipid-associated sialic acid, and fucose in precancerous lesion and cancer of the oral cavity.
    Rao VR; Krishnamoorthy L; Kumaraswamy SV; Ramaswamy G
    Cancer Detect Prev; 1998; 22(3):237-40. PubMed ID: 9618045
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantitative evaluation of serum fucose in oral squamous cell carcinoma patients.
    Parwani RN; Parwani SR
    J Cancer Res Ther; 2011; 7(2):143-7. PubMed ID: 21768700
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum fucosylation changes in oral cancer and oral precancerous conditions: alpha-L-fucosidase as a marker.
    Shah M; Telang S; Raval G; Shah P; Patel PS
    Cancer; 2008 Jul; 113(2):336-46. PubMed ID: 18521898
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of Serum Fucose Levels in Leukoplakia and Oral Cancer Patients.
    Rai NP; Anekar J; Shivaraja Shankara YM; Divakar DD; Al Kheraif AA; Ramakrishnaiah R; Sebastian R; Raj AC; Al-Hazmi A; Mustafa SM
    Asian Pac J Cancer Prev; 2015; 16(17):7497-500. PubMed ID: 26625751
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum fucosyl transferase activity and serum fucose levels as diagnostic tools in malignancy.
    Sen U; Guha S; Chowdhury JR
    Acta Med Okayama; 1983 Dec; 37(6):457-62. PubMed ID: 6666675
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of serum beta 2-microglobulin in oral cancer.
    Manzar W; Raghavan MR; Aroor AR; Keshavamurthy KR
    Aust Dent J; 1992 Feb; 37(1):39-42. PubMed ID: 1567293
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum total glutathione-s-transferase levels in oral cancer.
    Prabhu K; Bhat GP
    J Cancer Res Ther; 2007; 3(3):167-8. PubMed ID: 18079581
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlation of serum biomarkers (TSA & LSA) and epithelial dysplasia in early diagnosis of oral precancer and oral cancer.
    Sawhney H; Kumar CA
    Cancer Biomark; 2011-2012; 10(1):43-9. PubMed ID: 22297551
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum hyaluronan levels in oral cancer patients.
    Xing RD; Chang SM; Li JH; Li H; Han ZX
    Chin Med J (Engl); 2008 Feb; 121(4):327-30. PubMed ID: 18304465
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum pseudocholinesterase activity & protein bound fucose level in oral malignancy.
    Sen R; Sur R; Dasgupta R; Mazumder GC
    Indian J Cancer; 1987 Dec; 24(4):242-50. PubMed ID: 3505513
    [No Abstract]   [Full Text] [Related]  

  • 14. Serum fucose levels in gynaecological disorders including carcinoma cervix.
    Bandlish U; Prabhakar BR; Virmani U
    J Indian Med Assoc; 1991 Sep; 89(9):250-1. PubMed ID: 1795106
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Total sialic acid as a tumor marker for oral cancer.
    Xing RD; Wang ZS; Li CQ; Tang QY; Jiang CB; Zhang YZ
    Int J Biol Markers; 1994; 9(4):239-42. PubMed ID: 7836802
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum fucose as a monitor for recurrent malignancy.
    Wallack MK; Brown AS; Rosato EF; Rubin S; Johnson JL; Rosato FE
    J Surg Oncol; 1978; 10(1):39-44. PubMed ID: 628216
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical value of protein-bound fucose in patients with carcinoma and other diseases.
    Lambana S
    Gan; 1976 Jun; 67(3):379-88. PubMed ID: 1001865
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Estimation of serum leptin in oral squamous cell carcinoma.
    Gharote HP; Mody RN
    J Oral Pathol Med; 2010 Jan; 39(1):69-73. PubMed ID: 19817969
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circulating MicroRNA-21 Expression as a Novel Serum Biomarker for Oral Sub-Mucous Fibrosis and Oral Squamous Cell Carcinoma.
    Singh P; Srivastava AN; Sharma R; Mateen S; Shukla B; Singh A; Chandel S
    Asian Pac J Cancer Prev; 2018 Apr; 19(4):1053-1057. PubMed ID: 29699056
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Roles of preoperative C-reactive protein are more relevant in buccal cancer than other subsites.
    Tai SF; Chien HT; Young CK; Tsao CK; de Pablo A; Fan KH; Liao CT; Wang HM; Kang CJ; Chang JT; Huang SF
    World J Surg Oncol; 2017 Feb; 15(1):47. PubMed ID: 28209200
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.